Skip to main content

Publications

featured publications

  • Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial.

    Blood

    Authors: Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jiménez-Yuste, Flora Peyvandi, Guy Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin Fijnvandraat

  • Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group.

    Hamostaseologie

    Authors: Christian Pfrepper, Robert Klamroth, Johannes Oldenburg, Katharina Holstein, Hermann Eichler, Christina Hart, Patrick Moehnle, Kristina Schilling, Karolin Trautmann-Grill, Mohammed Alrifai, Cihan Ay, Wolfgang Miesbach, Paul Knoebl, Andreas Tiede

  • Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.

    European journal of haematology

    Authors: Mark T Reding, María Teresa Álvarez-Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg

  • Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.

    The Lancet. Haematology

    Authors: Andreas Tiede, Christina Hart, Paul Knöbl, Richard Greil, Johannes Oldenburg, Ulrich J Sachs, Wolfgang Miesbach, Christian Pfrepper, Karolin Trautmann-Grill, Katharina Holstein, Jan Pilch, Patrick Möhnle, Christoph Schindler, Carmen Weigt, Dorothea Schipp, Marcus May, Christiane Dobbelstein, Fabius J Pelzer, Sonja Werwitzke, Robert Klamroth

  • Two-center validation of assays for the detection of binding and neutralizing anti-factor VIII antibodies.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Jens Müller, Sonja Neimanis, Jörg Kahle, Thilo Albert, Stephan Schultze Strasser, Bonita Rup, Bernd Pötzsch, Christoph Königs, Johannes Oldenburg

  • Heterozygosity in FXIII genes and the manifestation of mild inherited FXIII Deficiency.

    Journal of thrombosis and haemostasis : JTH

    Authors: Sneha Singh, Behnaz Pezeshkpoor, Muhammad Ahmer Jamil, Johannes Dodt, Amit Sharma, Vasanth Ramar, Vytautas Ivaskevicius, Emma Hethershaw, Helen Philippou, Anna Pavlova, Johannes Oldenburg, Arijit Biswas

  • Functional determination of emicizumab in presence of Factor VIII activity.

    Journal of thrombosis and haemostasis : JTH

    Authors: Nasim Shahidi Hamedani, Anouk Anna Marie Therese Donners, Matthijs van Luin, Simone Gasper, Heiko Rühl, Claudia Klein, Thilo Albert, Mohsin El Amrani, Bernd Pötzsch, Johannes Oldenburg, Jens Müller

  • Cases of less-than-expected FVIII activity in previously treated patients during post-marketing surveillance of N8-GP.

    Haemophilia : the official journal of the World Federation of Hemophilia

    Authors: Johannes Oldenburg, Gary Benson, Pratima Chowdary, Susan Halimeh, Tadashi Matsushita, Anne Nørland, Mohd Nawi Wahid, Laszlo Nemes

  • Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults.

    Research and practice in thrombosis and haemostasis

    Authors: Barbara A Konkle, Johannes Oldenburg, John Pasi, Roshni Kulkarni, Beatrice Nolan, Johnny Mahlangu, Guy Young, Simon A Brown, Ingrid Pabinger, Amy Shapiro, Claude Négrier, Victor Blanchette, Margaret V Ragni, Jennifer Dumont, Stefan Lethagen

  • Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study.

    Therapeutic advances in hematology

    Authors: Carmen Escuriola Ettingshausen, Cedric Hermans, Pål A Holme, Ana R Cid, Kate Khair, Johannes Oldenburg, Claude Négrier, Jaco Botha, Aurelia Lelli, Jerzy Windyga